{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:16:49Z","timestamp":1791908209757,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Slovenian Technology Agency TIA","award":["VALOR08-02"],"award-info":[{"award-number":["VALOR08-02"]}]},{"name":"SPIRIT Slovenija","award":["P-MR-09\/104"],"award-info":[{"award-number":["P-MR-09\/104"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.bbapap.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T18:24:38Z","timestamp":1457547878000},"page":"645-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Dual mechanism of action of the atypical tetracycline chelocardin"],"prefix":"10.1016","volume":"1864","author":[{"given":"Jennifer J.","family":"Stepanek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeja","family":"Luke\u017ei\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Teichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrvoje","family":"Petkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-8829","authenticated-orcid":false,"given":"Julia E.","family":"Bandow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2016.03.004_bb0005","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1515\/hsz-2013-0292","article-title":"Tetracycline antibiotics and resistance mechanisms","volume":"395","author":"Nguyen","year":"2014","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ja.2013.86","article-title":"Antibiotics in the clinical pipeline in 2013","volume":"66","author":"Butler","year":"2013","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0020","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1128\/AAC.06187-11","article-title":"Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic","volume":"56","author":"Grossman","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/AAC.36.4.876","article-title":"Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes","volume":"36","author":"Oliva","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/AAC.38.4.637","article-title":"Tetracycline analogs whose primary target is not the bacterial ribosome","volume":"38","author":"Chopra","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0035","first-page":"560","article-title":"Clinico-pharmacological investigation of chelocardine in patients suffering from urinary tract infection (author's transl)","volume":"99","author":"Molnar","year":"1977","journal-title":"Lijec. Vjesn."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0040","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1099\/mic.0.070995-0","article-title":"Identification of the chelocardin biosynthetic gene cluster from Amycolatopsis sulphurea: a platform for producing novel tetracycline antibiotics","volume":"159","author":"Luke\u017ei\u010d","year":"2013","journal-title":"Microbiology"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0045","article-title":"Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering","author":"Le\u0161nik","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/AAC.36.5.913","article-title":"Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli","volume":"36","author":"Oliva","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0005-2787(71)90019-0","article-title":"Mode of action of \u03b2-chelocardin","volume":"238","author":"Mao","year":"1971","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0060","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1128\/AAC.01710-10","article-title":"Further characterization of Bacillus subtilis antibiotic biosensors and their use for antibacterial mode-of-action studies","volume":"55","author":"Mariner","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0065","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1128\/AAC.35.11.2306","article-title":"Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome","volume":"35","author":"Rasmussen","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0070","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1021\/ja00435a039","article-title":"Chemical\u2013structural properties of tetracycline derivatives. 1. Molecular structure and conformation of the free base derivatives","volume":"98","author":"Stezowski","year":"1976","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0075","doi-asserted-by":"crossref","first-page":"7655","DOI":"10.1021\/ja00520a003","article-title":"Chemical\u2013structural properties of tetracycline derivatives. 7. Evidence for the coexistence of the zwitterionic and nonionized forms of the free base in solution","volume":"101","author":"Hughes","year":"1979","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0080","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/pmic.201100046","article-title":"Proteomic signatures in antibiotic research","volume":"11","author":"Wenzel","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0085","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1128\/AAC.47.3.948-955.2003","article-title":"Proteomic approach to understanding antibiotic action","volume":"47","author":"Bandow","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0090","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1128\/AAC.00078-11","article-title":"Proteomic signature of fatty acid biosynthesis inhibition available for in vivo mechanism-of-action studies","volume":"55","author":"Wenzel","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0095","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1128\/AAC.01380-12","article-title":"Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane","volume":"56","author":"Wenzel","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0100","doi-asserted-by":"crossref","first-page":"E1409","DOI":"10.1073\/pnas.1319900111","article-title":"Small cationic antimicrobial peptides delocalize peripheral membrane proteins","volume":"111","author":"Wenzel","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0105","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1128\/AAC.50.4.1449-1457.2006","article-title":"Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies","volume":"50","author":"Bonelli","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0110","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/JB.81.5.741-746.1961","article-title":"Requirements for transformation in Bacillus subtilis","volume":"81","author":"Anagnostopoulos","year":"1961","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0115","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1099\/00221287-139-9-2041","article-title":"Temporal activation of \u03b2-glucanase synthesis in Bacillus subtilis is mediated by the GTP pool","volume":"139","author":"St\u00fclke","year":"1993","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1615-9861(200104)1:5<699::AID-PROT699>3.0.CO;2-C","article-title":"A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels","volume":"1","author":"Rabilloud","year":"2001","journal-title":"Proteomics"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0125","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/pmic.200701184","article-title":"Improved image analysis workflow for 2-D gels enables large-scale 2-D gel-based proteomics studies \u2014 COPD biomarker discovery study","volume":"8","author":"Bandow","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0130","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1021\/cb4000844","article-title":"Analysis of the mechanism of action of potent antibacterial hetero-tri-organometallic compounds: a structurally new class of antibiotics","volume":"8","author":"Wenzel","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"ProteomeXchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Vizca\u00edno","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/EC.00241-14","article-title":"A fungal sarcolemmal membrane-associated protein (SLMAP) homolog plays a fundamental role in development and localizes to the nuclear envelope, endoplasmic reticulum, and mitochondria","volume":"14","author":"Nordzieke","year":"2015","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0145","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/1011-1344(90)85037-W","article-title":"Transmembrane potential measurement with carbocyanine dye diS-C3-(5): fast fluorescence decay studies","volume":"4","author":"Sip","year":"1990","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0150","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1128\/AAC.01620-09","article-title":"Antimicrobial mechanism of action of transferrins: selective inhibition of H+-ATPase","volume":"54","author":"Andr\u00e9s","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nmeth.2369","article-title":"Proteoform: a single term describing protein complexity","volume":"10","author":"Smith","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0160","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1002\/(SICI)1522-2683(19990801)20:11<2149::AID-ELPS2149>3.0.CO;2-N","article-title":"Diagnosis of cellular states of microbial organisms using proteomics","volume":"20","author":"VanBogelen","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0165","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/pmic.201200556","article-title":"Extracting iron and manganese from bacteria with ionophores \u2014 a mechanism against competitors characterized by increased potency in environments low in micronutrients","volume":"13","author":"Raatschen","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc01f02s26","article-title":"2-D gel-based proteomic approaches to antibiotic drug discovery","author":"Raatschen","year":"2012","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0175","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0304-4165(74)90204-9","article-title":"Stability of sodium and potassium complexes of valinomycin","volume":"372","author":"Rose","year":"1974","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00425076","article-title":"Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin","volume":"149","author":"Sahl","year":"1987","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0185","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1021\/bi049476b","article-title":"Assembly and stability of nisin\u2013lipid II pores","volume":"43","author":"Hasper","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0190","doi-asserted-by":"crossref","first-page":"19898","DOI":"10.1074\/jbc.M301463200","article-title":"Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes","volume":"278","author":"Breukink","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0195","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1074\/mcp.M300074-MCP200","article-title":"Complementary analysis of the Mycobacterium tuberculosis proteome by two-dimensional electrophoresis and isotope-coded affinity tag technology","volume":"3","author":"Schmidt","year":"2004","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0200","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1074\/mcp.M112.019372","volume":"12","author":"Thiede","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbapap.2016.03.004_bb0205","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1074\/jbc.M307889200","article-title":"Organization of the AAA+ adaptor protein PspA is an oligomeric ring","volume":"279","author":"Hankamer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0210","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.febslet.2008.09.002","article-title":"PspA can form large scaffolds in Escherichia coli","volume":"582","author":"Standar","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0215","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1128\/JB.00543-10","article-title":"In-depth profiling of the LiaR response of Bacillus subtilis","volume":"192","author":"Wolf","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-2911(01)44011-2","article-title":"General stress response of Bacillus subtilis and other bacteria","volume":"44","author":"Hecker","year":"2001","journal-title":"Adv. Microb. Physiol."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0225","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1128\/jb.177.13.3771-3780.1995","article-title":"Separate mechanisms activate \u03c3B of Bacillus subtilis in response to environmental and metabolic stresses","volume":"177","author":"Voelker","year":"1995","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0230","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1128\/JB.183.21.6422-6428.2001","article-title":"Catalytic function of an \u03b1\/\u03b2 hydrolase is required for energy stress activation of the \u03c3B transcription factor in Bacillus subtilis","volume":"183","author":"Brody","year":"2001","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0235","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.coph.2008.06.008","article-title":"How many modes of action should an antibiotic have?","volume":"8","author":"Br\u00f6tz-Oesterhelt","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0240","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.clinthera.2004.11.014","article-title":"Daptomycin: a cyclic lipopeptide antimicrobial agent","volume":"26","author":"Jeu","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0245","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/383472","article-title":"Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens","volume":"38","author":"Carpenter","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbapap.2016.03.004_bb0250","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/dkh546","article-title":"Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections","volume":"55","author":"Steenbergen","year":"2005","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963916300401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963916300401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T22:53:25Z","timestamp":1600296805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963916300401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1570963916300401"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2016.03.004","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual mechanism of action of the atypical tetracycline chelocardin","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}